Phosphatidylinositol-4,5-bisphosphate 3-kinases (also known as phosphatidylinositol 3-kinase) are a family of enzymes involved in several signaling cascade responses for cell growth, survival, proliferation, motility and morphology. A disorder of each of the pathways may contribute to the development of cancer. Elevated PI3K kinase activity is commonly associated with multiple cancers. PI3K can be classified into 3 classes, with different structures and functions. The most widely studied is Class IA PI3K with four types of catalytic subunits, namely p110α, β, δ, and γ. PI3K is involved in various immune responses, and is produced in different immune cells. p110α and p110β proteins are commonly expressed, and the p110δ and p110γ isoforms of PI3K have specific roles in the regulation of multiple aspects of immune defense and inflammation.
BOC Sciences has developed a library to provide potential small-molecule inhibitors of δ, and γ isoforms of PI3K.
Figure 1. The class I PI3K family. (Akinleye, A.; et al. 2013)
At BOC Sciences, our PI3K δ and γ subunits inhibitors library is designed based on pharmacophore approach
Figure 2. Schematic representation of the PI3K signaling pathway. (Akinleye, A.; et al. 2013)
BOC Sciences provides professional, rapid and high-quality services of Phosphatidylinositol-4,5-bisphosphate 3-kinases (PI3K) δ and γ Subunits Inhibitors Library design at competitive prices for global customers. Personalized and customized services of Phosphatidylinositol-4,5-bisphosphate 3-kinases (PI3K) δ and γ Subunits Inhibitors Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.